priavoid.com
  • Home
  • About us
    • Overview
    • Strategy
    • Management
    • Supervisory Board
    • Scientific Advisory Board
    • History
  • Drug Development
    • Therapeutic Focus
    • Technology
    • Pipeline
  • Investors and Media
    • News
    • Events
    • Partnering
    • Archive
  • Contact us
    • Careers
Seite wählen

Prof. Willbold´s interview with PharmaVentures

November 14th, 2017

Learn more
Düsseldorf-Jülich Symposium on Neurodegenera7ve Diseases 2017 Bildquelle: Fotolia

Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017.

News & Events:

DGN Kongress 2019

DGN Kongress 2019
AAIC 2019

AAIC 2019
Keystone Symposium

Keystone Symposium
Neuro4D Conference

Neuro4D Conference
Seed Investment

Seed Investment
CEOs of Priavoid

CEOs of Priavoid
AD/PD 2019 – Lisbon

AD/PD 2019 – Lisbon
BioRiver Boost! 2018

BioRiver Boost! 2018
The Nobel Prize

The Nobel Prize
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures
ISO 9001:2015 certification

ISO 9001:2015 certification
Science September 7th, 2017

Science September 7th, 2017
Clinical trial with PRI-002

Clinical trial with PRI-002
  • Home
  • Investors and Media
  • Legal Notice
  • Privacy Policy
  • Contact us
Copyright © 2019 Priavoid GmbH